Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 27% ± 14% |
Insufficient scRNA-seq data for expression of LRP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 4146.22 | 245 / 245 | 99% | 47.03 | 499 / 502 |
brain | 99% | 7499.79 | 2610 / 2642 | 100% | 44.65 | 703 / 705 |
ovary | 100% | 9158.77 | 180 / 180 | 96% | 38.88 | 414 / 430 |
breast | 100% | 3264.14 | 459 / 459 | 96% | 22.59 | 1074 / 1118 |
adrenal gland | 100% | 3827.73 | 258 / 258 | 95% | 45.30 | 218 / 230 |
liver | 100% | 3049.85 | 226 / 226 | 92% | 25.40 | 375 / 406 |
thymus | 100% | 3116.32 | 652 / 653 | 89% | 17.10 | 541 / 605 |
stomach | 96% | 1907.39 | 344 / 359 | 88% | 24.68 | 252 / 286 |
pancreas | 96% | 1324.33 | 316 / 328 | 87% | 13.90 | 154 / 178 |
lung | 97% | 1686.75 | 559 / 578 | 84% | 16.37 | 971 / 1155 |
bladder | 95% | 3295.29 | 20 / 21 | 85% | 18.91 | 427 / 504 |
intestine | 95% | 2474.63 | 915 / 966 | 85% | 21.01 | 448 / 527 |
uterus | 99% | 3266.08 | 169 / 170 | 75% | 17.62 | 343 / 459 |
esophagus | 89% | 2801.47 | 1289 / 1445 | 74% | 18.90 | 136 / 183 |
skin | 98% | 1818.82 | 1770 / 1809 | 60% | 13.19 | 284 / 472 |
kidney | 82% | 1167.87 | 73 / 89 | 64% | 10.01 | 577 / 901 |
adipose | 100% | 3641.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 33.66 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.61 | 1 / 1 |
blood vessel | 99% | 2802.07 | 1325 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 1994.35 | 790 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 1680.16 | 817 / 861 | 0% | 0 | 0 / 0 |
spleen | 82% | 945.47 | 197 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 51% | 6.62 | 23 / 45 |
peripheral blood | 23% | 236.50 | 210 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
Gene name | LRP3 |
Protein name | Low-density lipoprotein receptor-related protein 3 (LRP-3) (105 kDa low-density lipoprotein receptor-related protein) (hLRp105) LDL receptor related protein 3 |
Synonyms | |
Description | FUNCTION: Probable receptor, which may be involved in the internalization of lipophilic molecules and/or signal transduction. Its precise role is however unclear, since it does not bind to very low density lipoprotein (VLDL) or to LRPAP1 in vitro. |
Accessions | ENST00000253193.9 O75074 V9GYG8 ENST00000592484.5 |